Fintel reports that on February 3, 2025, HC Wainwright & Co. initiated coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...

The innovation, he says, could transform the way scientists measure and address genomic breaks in gene-editing systems.

By creating gene editors not found in nature, or optimizing existing editors, AI can improve the accuracy, effectiveness, and accessibility of gene editing.

Encasing CRISPR tools in oil droplets offers a fast-track approach to conducting extensive genetic screens in animals.

Potent in vivo gene editing in skeletal muscle of non-human primates by a novel, ultracompact CRISPR system delivered via a single AAV vector.

H.C. Wainwright analyst Mitchell Kapoor initiated coverage of Crispr Therapeutics (CRSP) with a Buy rating and $65 price target The firm says ...

One sickle cell patient told ITV News the new gene therapy being rolled out for use on the NHS means they "finally have something to look towards". | ITV National News ...

Overnight DeepSeek is the role model of the startup ecosystem. It is demonstrating real-time to every business, idea, or ...

A mouse with two dads — or a bi-paternal mouse — has made it to adulthood. Several mice, in fact. As detailed in a study published in the journal Cell Stem Cell, scientists achieved this feat of ...

The research shows that as long as essential genes remain intact, our genomes can tolerate significant structural changes, ...

After more than a decade of work, researchers have reached a major milestone in their efforts to re-engineer life in the lab, ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.